Tiagabine Hydrochloride (Teva Pharmaceuticals USA, Inc.)
Welcome to the PulseAid listing for the Tiagabine Hydrochloride drug offered from Teva Pharmaceuticals USA, Inc.. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA, Inc. |
| NON-PROPRIETARY NAME: | Tiagabine Hydrochloride |
| SUBSTANCE NAME: | TIAGABINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
| START MARKETING DATE: | 2016-06-03 |
| END MARKETING DATE: | 0000-00-00 |
Tiagabine Hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | Tiagabine Hydrochloride from Teva Pharmaceuticals USA, Inc. |
| LABELER NAME: | Teva Pharmaceuticals USA, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2(mg/1) |
| START MARKETING DATE: | 2016-06-03 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0093-5030_02b715ab-edd5-4d15-ac64-26521937b4b8 |
| PRODUCT NDC: | 0093-5030 |
| APPLICATION NUMBER: | NDA020646 |
Other TIAGABINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
